Abiopharma

New Form 8-K - Aptevo Therapeutics Inc. Filed: 2025-06-20 AccNo: 0000950170-25-088494 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits